RYAN ARTHUR F — SEC Form 4 filings
SEC reporting owner CIK 1187443. 17 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-02-05 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 225 legs across 15 filings — 1,500 shares, $1,351,212 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 200 shares @ $650.15 ($130,030) in REGENERON PHARMACEUTICALS, INC., filed 2026-07-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 17 | — | 225 legs · 1,500 sh · $1,351,212 | 4 |
Form 4 filings — RYAN ARTHUR F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 200 @ $650.15 | EDGAR |
| 2026-05-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 5 @ $701.76 · Sale (S): 15 @ $702.46 · Sale (S): 24 @ $703.46 · Sale (S): 15 @ $704.28 · Sale (S): 14 @ $705.56 · Sale (S): 7 @ $706.74 · +6 more | EDGAR |
| 2026-04-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $771.32 · Sale (S): 3 @ $772.76 · Sale (S): 8 @ $773.59 · Sale (S): 8 @ $774.58 · Sale (S): 14 @ $775.58 · Sale (S): 13 @ $776.62 · +3 more | EDGAR |
| 2026-03-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 7 @ $777.46 · Sale (S): 2 @ $778.30 · Sale (S): 5 @ $779.69 · Sale (S): 3 @ $780.69 · Sale (S): 2 @ $781.21 · Sale (S): 2 @ $782.62 · +7 more | EDGAR |
| 2026-02-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $775.63 · Sale (S): 10 @ $776.59 · Sale (S): 57 @ $777.56 · Sale (S): 12 @ $778.53 · Sale (S): 5 @ $779.41 · Sale (S): 1 @ $780.09 · +7 more | EDGAR |
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3 @ $1,041.35 · Sale (S): 1 @ $1,042.31 · Sale (S): 5 @ $1,043.39 · Sale (S): 9 @ $1,044.62 · Sale (S): 7 @ $1,045.27 · Sale (S): 9 @ $1,046.53 · +11 more | EDGAR |
| 2024-09-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 4 @ $1,166.52 · Sale (S): 1 @ $1,167.27 · Sale (S): 4 @ $1,168.99 · Sale (S): 4 @ $1,170.40 · Sale (S): 16 @ $1,172.75 · Sale (S): 8 @ $1,174.32 · +14 more | EDGAR |
| 2024-08-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $1,053.22 · Sale (S): 1 @ $1,058.90 · Sale (S): 1 @ $1,062.71 · Sale (S): 6 @ $1,065.39 · Sale (S): 4 @ $1,066.33 · Sale (S): 1 @ $1,067.53 · +24 more | EDGAR |
| 2024-08-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $1,100.03 | EDGAR |
| 2024-07-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3 @ $1,047.11 · Sale (S): 2 @ $1,050.87 · Sale (S): 7 @ $1,051.58 · Sale (S): 6 @ $1,052.19 · Sale (S): 8 @ $1,053.60 · Sale (S): 1 @ $1,054.25 · +13 more | EDGAR |
| 2024-06-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 2 @ $979.40 · Sale (S): 3 @ $980.16 · Sale (S): 3 @ $981.95 · Sale (S): 1 @ $982.99 · Sale (S): 2 @ $984.52 · Sale (S): 2 @ $988.66 · +10 more | EDGAR |
| 2024-05-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3 @ $889.50 · Sale (S): 2 @ $890.75 · Sale (S): 7 @ $891.52 · Sale (S): 9 @ $892.50 · Sale (S): 5 @ $893.16 · Sale (S): 2 @ $895.38 · +17 more | EDGAR |
| 2024-04-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 2 @ $957.78 · Sale (S): 2 @ $958.86 · Sale (S): 9 @ $959.47 · Sale (S): 15 @ $960.53 · Sale (S): 14 @ $961.59 · Sale (S): 9 @ $962.42 · +3 more | EDGAR |
| 2024-03-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $967.50 · Sale (S): 1 @ $968.66 · Sale (S): 1 @ $969.18 · Sale (S): 4 @ $970.38 · Sale (S): 1 @ $971.75 · Sale (S): 2 @ $972.29 · +15 more | EDGAR |
| 2024-02-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1 @ $939.53 · Sale (S): 6 @ $941.91 · Sale (S): 5 @ $942.50 · Sale (S): 3 @ $943.54 · Sale (S): 1 @ $944.66 · Sale (S): 3 @ $947.37 · +15 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187443 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →